Its a triple-agonist peptide , meaning it activates three major systems simultaneously: GLP-1 reduces hunger and slows digestion GIP enhances metabolic efficiency Glucagon increases energy expenditure This combination leads to: Eating less without constant willpower Better blood sugar regulation Increased calorie burn at rest The clinical data is already strong Even in earlier trials, the results were hard to ignore: Up to ~24% total body weight loss in Phase 2 studies Around 17% weight loss in type 2 diabetes patients , alongside improved glucose control Up to 82% reduction in liver fat in individuals with fatty liver disease This isnt just weight lossits full metabolic change
Makes the skin soft and youthful
If you would like one-on-one help with your nutrition, our staff nutritionist, Lindsay Christensen, can work with you to create a customized nutrition program designed to help facilitate your healing process
Combined with a healthy diet and exercise program, these treatments create a well-rounded approach to achieving lasting results
Semaglutide and tirzepatide are both medications designed to help patients with type 2 diabetes manage their symptoms, but they are also highly effective for weight loss
During ObesityWeek in November 2024, the poster presentation included newly reported data from a subset of patients assessed for pharmacokinetic (PK) measures